# Pulse Biosciences, Inc.: Form 8-K/A, filed Mar 2, 2026

- Company: [Pulse Biosciences, Inc.](/companies/plse.md) (CIK 1625101)
- Form: 8-K/A
- Filed: 2026-03-02
- Accepted by EDGAR: Mar 2, 2026, 09:21 ET
- Period: 2026-02-27
- Accession: 0001437749-26-006269
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/plse20260228d_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/plse20260228d_8ka.htm

Filed Mar 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-006269. Last ingested by Listed: Nov 6, 2026, 12:23 ET. No prices; not investment advice.